By Lauren Berg (October 2, 2025, 21:48 PM) – The government urged a Federal Massachusetts judge to decide on the fact that Regeneron Pharmaceuticals “naturally or before” made the providers showed false claims for his macular drug of degeneration Eylea, for his standard for the fact of doing a false certification.
Law360 is on this, so you are too.
A Law360 subscription puts you at the center of legal problems, trends and rapidly evolving developments so that you can act with speed and confidence. More than 200 articles are published daily on more than 60 subjects, industries, areas of practice and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile application
- Advanced search
- Judge the information
- Real -time alerts
- 450K + archived articles available you
And more!
Law360 experience today with a free 7 -day trial.
